Acute orogastric administration of alpha-tocopherol protects from ozone-induced changes in rat striatal catecholamine levels.
González-Piña
R
R
higgo@prodigy.net.mx
Alfaro-Rodríguez
A
A
Castorena-Maldonado
A
A
Morales Martinez
J J
JJ
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D002395:Catecholamines / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D008297:Male; D017072:Neostriatum / Q000187:drug effects / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D010083:Oxidants, Photochemical / Q000633:toxicity*; D010126:Ozone / Q000037:antagonists & inhibitors* / Q000633:toxicity*; D051381:Rats; D017208:Rats, Wistar; D024502:alpha-Tocopherol / Q000494:pharmacology*
D000975:Antioxidants; D002395:Catecholamines; D010083:Oxidants, Photochemical; D015102:3,4-Dihydroxyphenylacetic Acid; D010126:Ozone; D024502:alpha-Tocopherol; D004298:Dopamine; D009638:Norepinephrine